Sector pending / Pharmaceutical PreparationsUpdated 2026-05-10 22:07 UTC

FRA/7XY stock hub

FRA/7XY has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

FRA/7XYis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

364.4M

Frankfurt Stock Exchange

Market data

Price

Recent price action with selectable time range.

FRA/7XYFRA/7XY

—

Loading chart…

In the news

Latest news · FRA/7XY

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E21

P25 n/aP50 n/aP75 n/a

Trailing P/E81.1

P25 n/aP50 n/aP75 n/a

ROE0.7

P25 n/aP50 n/aP75 n/a

ROIC1.6

P25 n/aP50 n/aP75 n/a

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All FRA/7XY market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

211

Groups with data

Currency

SEK

Showing 211 of 211 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	Sweden
Country code	DE
Employees	591
Employees Change	39%
Employees Change Percent	6.84
Enterprise value	EUR 517.2M
Exchange	Frankfurt Stock Exchange
Financial currency	SEK
First seen	2026-05-10
Industry	Pharmaceutical Preparations
Last refreshed	2026-05-10
Market cap	EUR 364.4M
Price	EUR 2.26
Price currency	EUR
Rev Per Employee	416,409.71x
Sic	2834
Symbol	fra/7XY
Website	https://www.swedencare.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	1.23%
EV Earnings	115.12x
EV/EBIT	26.93x
EV/EBITDA	10.9x
EV/FCF	22.95x
EV/Sales	2.08x
FCF yield	6.18%
Forward P/E	21.03x
P/B ratio	0.58x
P/E ratio	81.11x
P/S ratio	1.48x
PE Ratio10 Y	103.42x
PE Ratio3 Y	104.66x
PE Ratio5 Y	146.7x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	7.64%
EBITDA Margin	17.49%
FCF margin	9.16%
Gross margin	58.56%
Gross Profit	EUR 144.1M
Gross Profit Growth	5.16%
Gross Profit Growth Q	4.08%
Gross Profit Growth3 Y	11.56%
Gross Profit Growth5 Y	53.76%
Net Income	EUR 4.5M
Net Income Growth	-46.82%
Net Income Growth Q	-25.94%
Net Income Growth3 Y	-20.2%
Net Income Growth5 Y	7.82%
Pretax Margin	2.78%
Profit Margin	1.83%
Profit Per Employee	EUR 7,602
ROA	1.32
Roa5y	1.6
ROCE	2.21
ROE	0.69
Roe5y	1.61
ROIC	1.6
Roic5y	2.45

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	-36.09%
Cagr3y	-11.77%
Div CAGR3	10.21%
EPS Growth	-47.13
EPS Growth Q	-26.4
EPS Growth3 Y	-20.44
EPS Growth5 Y	-3.17
FCF Growth	-27.61%
FCF Growth Q	-37.46%
FCF Growth3 Y	-0.25%
FCF Growth5 Y	40.29%
OCF Growth	-23.31%
OCF Growth Q	-32.47%
OCF Growth10 Y	49.37%
OCF Growth3 Y	-2.01%
OCF Growth5 Y	43.54%
Revenue Growth	4.57x
Revenue Growth Q	1.43x
Revenue Growth3 Y	10.77x
Revenue Growth5 Y	51.66x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	EUR 0.28
Assets	EUR 888.4M
Cash	EUR 8.6M
Current Assets	EUR 105.9M
Current Liabilities	EUR 39.1M
Debt	EUR 159.8M
Debt EBITDA	EUR 3.42
Debt Equity	EUR 0.25
Debt FCF	EUR 7.09
Equity	EUR 631.8M
Interest Coverage	3.54
Liabilities	EUR 256.7M
Long Term Assets	EUR 782.6M
Long Term Liabilities	EUR 217.6M
Net Cash	EUR -151.2M
Net Cash By Market Cap	EUR -41.49
Net Debt EBITDA	EUR 3.51
Net Debt Equity	EUR 0.24
Net Debt FCF	EUR 6.71
Tangible Book Value	EUR -80.3M
Tangible Book Value Per Share	EUR -0.5

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	2.71
Inventory Turnover	2.25
Net Working Capital	EUR 62.5M
Quick ratio	1.29
Working Capital	EUR 66.2M
Working Capital Turnover	EUR 0.28

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-0.65%
Dividend Growth	13.36%
Dividend Growth Years	3%
Dividend per share	EUR 0.03
Dividend Years	6
Dividend Yield	1.15%
Ex Div Date	2026-04-24
Last Dividend	EUR 0.03
Payout Frequency	Annual
Payout Ratio	81.14%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	-36.07%
200-day SMA	2.95
3Y total return	-31.33%
50-day SMA	2.28
50-day SMA vs 200-day SMA	50under200
All Time High	15.58
All Time High Change	-85.53%
All Time High Date	2021-09-17
All Time Low	1.94
All Time Low Change	16.42%
All Time Low Date	2023-03-29
ATR	0.06
Ch YTD	-35.01
High	2.26
High52	4.27
High52 Date	2025-07-23
High52ch	-47.13%
Low	2.26
Low52	2.08
Low52 Date	2026-03-30
Low52ch	8.68%
Ma50ch	-1.27%
Price vs 200-day SMA	-23.51%
RSI	42.66
RSI Monthly	36.74
RSI Weekly	37.95
Sharpe ratio	-0.6x
Sortino ratio	-0.7
Total Return	0.51%
Tr YTD	-34.32
Tr1m	1.52%
Tr1w	-7.77%
Tr3m	2.43%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	EUR 18.8M
Operating Income Growth	-8.23
Operating Income Growth Q	15.93
Operating Income Growth3 Y	11.41
Operating Income Growth5 Y	33.06
Operating margin	7.64

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	51,050,469%
Net Borrowing	-16,065,428
Shares Insiders	12.77%
Shares Institutions	25.57%
Shares Qo Q	0%
Shares Yo Y	0.65%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	EUR 22.5M
Average Volume	0.1x
Bv Per Share	3.95
CAPEX	EUR -4.4M
Ch1m	0.45
Ch1w	-7.77
Ch1y	-36.75
Ch3m	1.35
Ch3y	-32.85
Ch6m	-27.96
Change	-3.01%
Change From Open	0
Close	2.33
Days Gap	-3.01
Depreciation Amortization	24,484,595.7
Earnings Date	2026-07-22
EBIT	EUR 18.8M
EBITDA	EUR 43M
EPS	EUR 0.03
F Score	7
FCF	EUR 22.5M
FCF EV Yield	4.36x
Financing CF	-19,566,461
Fiscal Year End	December
Founded	1,993
Goodwill	370,056,921.5
Graham Number	1.56382
Graham Upside	-30.65
Income Tax	EUR 2.3M
Investing CF	-46,268,710
Is Primary Listing	0
Last Earnings Date	2026-04-02
Last Report Date	2026-03-31
Lynch Fair Value	EUR 0.22
Lynch Upside	-90.36
Ma150	2.8
Ma150ch	-19.58%
Ma20	2.43
Ma20ch	-7.28%
Net CF	-39,369,869
Next Earnings Date	2026-07-22
Open	2.26
P FCF Ratio	16.17
P OCF Ratio	13.54
Payment Date	2026-04-30
Ppne	56,643,055.6
Price Date	2026-05-08
Price EBITDA	EUR 8.47
Relative Volume	5x
Revenue	246,098,137x
Tax By Revenue	0.95x
Tax Rate	34.27%
Tr6m	-27.19%

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

FRA/7XY dividend yield, growth & safety

Yield, payout sustainability, and the multi-year growth streak.

Dividend yield

+1.2%

$0.03 annual per share

Payout ratio

+81.1%

Share of earnings returned as dividends. Below 60% is generally sustainable.

5Y dividend CAGR

n/a

3 consecutive years of growth

Total shareholder yield

+0.5%

Next ex-dividend date: 2026-04-24

Performance

FRA/7XY stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns FRA/7XY?

Insider, institutional, and short-interest positioning.

Institutional ownership

+25.6%

Share of float held by funds and institutions

Insider ownership

+12.8%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

+0.6%

Negative means the company is buying back shares.

Technical

FRA/7XY momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

42.7

Neutral momentum band

Price vs 200-day MA

-23.5%

50/200-day relationship not available

Beta (5Y)

n/a

Sensitivity to the broader market

Sharpe ratio

-0.60

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About FRA/7XY

Hub-level FAQ points readers to the deeper analysis pages.

What is the current fra/7XY stock rating?

fra/7XY is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full fra/7XY analysis?

The full report lives at /stocks/fra/7XY/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for fra/7XY?

The latest report frames fra/7XY around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the fra/7XY page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.